Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 12:32 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 55 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Resurfacing Clear all

Conditions: Wrinkle, Rhytides
Interventions: Renuvion Dermal System; Device
Lead sponsor: Apyx Medical; Industry
Eligibility: 30 Years and older
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 4
States / cities: Sherman Oaks, California • Jacksonville, Florida • Sarasota, Florida + 1 more

Conditions: Arthritis
Interventions: Birmingham Hip Resurfacing; Device
Lead sponsor: Smith & Nephew, Inc.; Industry
Eligibility: 21 Years to 75 Years
Enrollment: 329 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2025
U.S. locations: 7
States / cities: Tucson, Arizona • Lake Charles, Louisiana • New York, New York + 4 more

Conditions: Scarring
Interventions: Application of Sterile 0.9% Saline Solution, Application of dHACM; Other
Lead sponsor: MiMedx Group, Inc.; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: San Diego, California

Conditions: Subjects With Severe, Refractory Sclerotic Skin Changes
Interventions: CO2 Laser, Ultrasound, Skin Biopsy; Device · Radiation · Diagnostic Test
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Hip Arthroplasty
Interventions: Extended Release Epidural Morphine (EREM), Placebo; Drug
Lead sponsor: Wake Forest University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Osteoarthritis, Avascular Necrosis, Rheumatoid Arthritis
Interventions: Cormet Hip Resurfacing System; Device
Lead sponsor: Corin; Industry
Eligibility: Not listed
Enrollment: 231 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2017
U.S. locations: 5
States / cities: Merritt Island, Florida • Sarasota, Florida • Springfield, Illinois + 2 more

Conditions: Skin Resurfacing
Interventions: OPUS system; Device
Lead sponsor: Alma Lasers; Industry
Eligibility: 18 Years to 75 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Pain
Interventions: LMX4, BLT; Drug
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years to 75 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Wounds
Interventions: Placebo gel, GLYC-101 gel (1.0 %); Drug
Lead sponsor: TR Therapeutics; Industry
Eligibility: 25 Years to 65 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: Beverly Hills, California

Conditions: Osteoarthritis of the Hip, Degenerative Joint Disease of Hip, Dysplasia; Hip
Interventions: Polymotion Hip Resurfacing (PHR) System; Device
Lead sponsor: JointMedica Inc.; Other
Eligibility: 21 Years to 65 Years
Enrollment: 238 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 8
States / cities: Tampa, Florida • Chicago, Illinois • Baltimore, Maryland + 5 more

Conditions: Osteoarthritis, Hip
Interventions: Hip Resurfacing, Total Hip Arthroplasty; Device
Lead sponsor: Spokane Joint Replacement Center; Other
Eligibility: 20 Years to 80 Years
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2018
U.S. locations: 1
States / cities: Spokane, Washington

Conditions: Osteoarthritis, Avascular Necrosis, Rheumatoid Arthritis
Interventions: Cormet Hip Resurfacing; Device
Lead sponsor: Corin; Industry
Eligibility: Not listed
Enrollment: 147 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 6
States / cities: Washington D.C., District of Columbia • Tampa, Florida • Baltimore, Maryland + 3 more

Conditions: Obesity, Weight Change Trajectory, Weight Change, Body
Interventions: Revita Duodenal Mucosal Resurfacing (DMR), Sham; Device
Lead sponsor: Fractyl Health Inc.; Industry
Eligibility: 21 Years to 70 Years
Enrollment: 315 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 32
States / cities: Phoenix, Arizona • Scottsdale, Arizona • Newport Beach, California + 24 more

Conditions: Melasma
Interventions: Tranexamic Acid; Drug
Lead sponsor: Laser and Skin Surgery Center of New York; Other
Eligibility: 18 Years to 50 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 2
States / cities: New York, New York • Houston, Texas

Conditions: Actinic Keratoses, Aging, Non-Melanoma Skin Cancer
Interventions: Fractionated Laser Resurfacing; Device
Lead sponsor: Wright State University; Other
Eligibility: 60 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2031
U.S. locations: 1
States / cities: Fairborn, Ohio

Conditions: Type 2 Diabetes
Interventions: Duodenal Mucosal Resurfacing (DMR), Duodenal Mucosal Resurfacing Sham (Sham); Device
Lead sponsor: Fractyl Health Inc.; Industry
Eligibility: 28 Years to 65 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 6
States / cities: Orlando, Florida • Boston, Massachusetts • Lebanon, New Hampshire + 3 more

Conditions: Facial Wrinkles, Rhytides
Interventions: J-Plasma; Device
Lead sponsor: Apyx Medical; Industry
Eligibility: 30 Years and older
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 3
States / cities: Miami, Florida • Sarasota, Florida • Alpharetta, Georgia

Conditions: Other and Unspecified Injury to Hip and Thigh
Interventions: Not listed
Lead sponsor: MicroPort Orthopedics Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 199 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Acquired Absence of Lower Limb, Scar Condition and Fibrosis of the Skin
Interventions: Fractional CO2 Laser Ablative Resurfacing; Procedure
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 21 Years to 70 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Miami, Florida • Tampa, Florida

Conditions: Rhytides
Interventions: AmnioFix plus Standard of Care, Standard of Care; Device · Procedure
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 100 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: Ends 2018
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Arthritis
Interventions: HRA; Device
Lead sponsor: Integra LifeSciences Corporation; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2014
U.S. locations: 1
States / cities: Bay Pines, Florida

Conditions: Cognition
Interventions: Not listed
Lead sponsor: Rothman Institute Orthopaedics; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Pain
Interventions: S-Caine™ Peel (lidocaine and tetracaine topical cream 7%/7%), Placebo Peel; Drug
Lead sponsor: ZARS Pharma Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005
U.S. locations: 3
States / cities: Clinton Township, Michigan • New York, New York

Conditions: Chemical Peel
Interventions: Aquaphor, HP828-101; Drug
Lead sponsor: Healthpoint; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 1
States / cities: Dallas, Texas

Search by objective public record fields.

Renuvion Dermal System for Dermal Resurfacing

A Safety and Efficacy Study of the Birmingham Hip Resurfacing System

Dehydrated Human Amnion/Chorion Membrane (dHACM) for Recovery After Fractionated Ablative CO2 Laser Resurfacing of the Face

Ablative Fractional Laser for Sclerotic GVHD-Associated Joint Contractures

Low Dose Extended-release Epidural and Lumbar Plexus Block Compared to Lumbar Plexus Block for Total Hip Resurfacing

Post-PMA Approval Study: 10 Year Follow-Up IDE Subjects

Unipolar Microplasma Radiofrequency Device: In-vivo Histologic Study

Comparison Study on Topical Anesthetic Agents (LMX4 and BLT) Prior to Fractional Skin Resurfacing

Efficacy Study of GLYC-101 to Evaluate Outcomes After Post-laser Ablation

Evaluate the Safety and Effectiveness of the Polymotion Hip Resurfacing (PHR) System Compared to Total Hip Arthroplasty

Dual Energy X-ray Absorptiometry (DXA) Comparison Hip Resurfacing Versus Total Hip Arthroplasty (THA)

Cormet Post-PMA Study: New Enrollment

Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide

Oral Tranexamic Acid and Laser for Treatment of Melasma

The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population

Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes

The Use of J-Plasma® for Dermal Resurfacing

CONSERVE Plus Post-Approval Study (PAS)

LASER Pilot Project

Comparison of AmnioFix Laser and Standard of Care Treatment

Ascension® Humeral Resurfacing Arthroplasty (HRA) Follow-Up Study

Cognition in Postoperative Total Hip Arthroplasty and Total Hip Resurfacing Patients

S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Non-Ablative Facial Laser Resurfacing in Adults

Post Treatment Care After Chemical Peel or Laser Resurfacing